Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy-Reference-Cited by-同舟云学术

Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy

Published:2016-03-14 Issue:5 Volume:27 Page:571-580
ISSN:1045-3873
Container-title:Journal of Cardiovascular Electrophysiology
language:en
Short-container-title:J Cardiovasc Electrophysiol

Author:

McLELLAN ALEX J.A.¹²³,ELLIMS ANDRIS H.¹,PRABHU SANDEEP¹²³,VOSKOBOINIK ALEX¹,ILES LEAH M.¹,HARE JAMES L.¹,KAYE DAVID M.¹,MACCIOCCA IVAN⁴,MARIANI JUSTIN A.¹,KALMAN JONATHAN M.²³,TAYLOR ANDREW J.¹,KISTLER PETER M.¹²³

Affiliation:

1. Department of Cardiovascular Medicine; Alfred Hospital and Baker IDI Heart and Diabetes Institute; Melbourne Victoria Australia

2. Cardiology Department; Royal Melbourne Hospital; Melbourne Victoria Australia

3. Faculty of Medicine, Dentistry, and Health Sciences; University of Melbourne; Melbourne Victoria Australia

4. Victorian Clinical Genetics Services; Murdoch Childrens Research Institute; Melbourne Victoria Australia

Funder

Victorian Government's Operational Infrastructure Funding

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jce.12948/fullpdf

Reference21 articles.

1. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Gersh;Circulation,2011

2. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study;Maron;Am J Cardiol,1981

3. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia;Spirito;Circulation,1994

4. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings;Fananapazir;Circulation,1992

5. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients;Monserrat;J Am Coll Cardiol,2003

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Interstitial fibrosis is associated with left atrial remodeling and adverse clinical outcomes in selected low-risk patients with hypertrophic cardiomyopathy”;International Journal of Cardiology;2024-08

2. Trans-Atlantic Differences in Approach to Sudden Death Prevention in Patients With Hypertrophic Cardiomyopathy;Canadian Journal of Cardiology;2024-05

3. Multiparametric Mapping via Cardiovascular Magnetic Resonance in the Risk Stratification of Ventricular Arrhythmias and Sudden Cardiac Death;Medicina;2024-04-24

4. Hitting the Target! Challenges and Opportunities for TGF-β Inhibition for the Treatment of Cardiac fibrosis;Pharmaceuticals;2024-02-20

5. A pilot study for risk stratification of ventricular tachyarrhythmia in hypertrophic cardiomyopathy with routine echocardiography parameters;Scientific Reports;2024-02-15